FAP-IN-7
FAP-IN-7 (Compound 5b) is a FAP18F enhances tumor retention with high selectivity and favorable pharmacokinetics. FAP-IN-7 can be used as a radiotracer for PET imaging and radionuclide therapy of cancers research[1].
Product Specifications
CAS Number
[3020777-28-7]
UNSPSC
12352005
Target
FAP
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
F[P-](F)(F)(F)(F)F.O=C(N1[C@@H](CC(F)(C1)F)C#N)CNC(C2=CC=NC3=C2C=C(OCCOCCOCC[N+](C)(C)CF)C=C3)=O
Molecular Formula
C26H33F9N5O5P
Molecular Weight
697.53
References & Citations
[1]Adhikari K, et al. Synthesis and Preclinical Evaluation of Druglike 18F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention. Bioconjug Chem. 2025 Aug 20;36 (8) :1887-1906
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1197067-01 0.5 mg (E-Coli)
Recombinant Takifugu rubripes Platelet-derived growth factor receptor beta (pdgfrb), partial
Ask
View Details MBS1197067-02 0.05 mg (Baculovirus)
Recombinant Takifugu rubripes Platelet-derived growth factor receptor beta (pdgfrb), partial
Ask
View Details 
MBS1197067-03 0.5 mg (Yeast)
Recombinant Takifugu rubripes Platelet-derived growth factor receptor beta (pdgfrb), partial
Ask
View Details 
MBS1197067-04 0.05 mg (Mammalian-Cell)
Recombinant Takifugu rubripes Platelet-derived growth factor receptor beta (pdgfrb), partial
Ask
View Details MBS1197067-05 1 mg (E-Coli)
Recombinant Takifugu rubripes Platelet-derived growth factor receptor beta (pdgfrb), partial
Ask
View Details MBS1197067-06 0.1 mg (Baculovirus)
Recombinant Takifugu rubripes Platelet-derived growth factor receptor beta (pdgfrb), partial
Ask
View Details